Golotimod
Description
Golotimod (SCV 07) is an immunomodulatory peptide with antibacterial activity that significantly improves the efficacy of anti-tuberculosis research, stimulates thymic and splenic cell proliferation, and improves macrophage function. Golotimod inhibits STAT3 signaling and modulates the duration and severity of oral mucositis in animal models receiving radiotherapy or radiotherapy combined with cisplatin. Golotimod has potential for research on recurrent genital herpes simplex virus type 2 (HSV-2).
Product Details
| Product Name | Golotimod |
| Biological activity | Golotimod (SCV-07), an immunomodulating peptide with antimicrobial activity, significantly increases the efficacy of antituberculosis therapy, stimulates thymic and splenic cell proliferation, and improves macrophage function. Golotimod (SCV-07) inhibits STAT3 signaling and modulates the duration and severity of oral mucositis in animal models that received radiation or a combination of radiation and Cisplatin. Golotimod (SCV-07) is also a potential therapeutic for recurrent genital herpes simplex virus type 2 (HSV-2). |
| Formula | C16H19N3O5 |
| CAS Number | 229305-39-9 |
| Appearance | Solid |
| Color | White to off-white |
| Storage | -20??C, Sealed storage, away from moisture and light |
